Proceedings · Session S-361 · filed September 30, 2026
Research Funding & PolicySession paper
War on the Rocks Asks Who Actually Funds America's R&D
War on the Rocks turns to science finance, asking who funds America's R&D — a question with direct consequences for lab budgets and portfolio risk.
By Tom Whitfield3 min read633 words
Summary
- War on the Rocks published an analysis asking who pays for America's research and development.
- Only the headline and publication attribution were available in the syndicated feed; the article body was not accessible for verification.
- The piece enters an established policy debate over the public-private split in US R&D funding.

War on the Rocks, a outlet better known for defense and national security analysis, has published a piece asking a question that sits at the center of every US science budget negotiation: who pays for America's research and development?
The article, distributed through Google News syndication on the War on the Rocks feed, addresses the division of labor between federal agencies, private industry, universities and nonprofit funders in sustaining the US research base. The question is not academic. For R&D managers at federal laboratories, research universities and corporate innovation units, the answer determines who bears the risk of early-stage science, who captures the returns, and where funding gaps emerge when either public or private spending retreats.
The debate the piece enters is a long-running one in US science policy. Federal support historically underwrote the bulk of basic research — the work that produces publishable findings rather than products — through agencies such as the National Science Foundation, the National Institutes of Health, the Department of Defense and the Department of Energy. Over recent decades, industry has come to account for the majority of total US R&D spending, but that spending skews toward late-stage development and applied work closer to market. The result, as policy researchers have repeatedly documented, is a potential underinvestment in the fundamental science that neither firms nor universities can easily fund on their own.
For laboratory directors and university research administrators, the funding mix has direct operational consequences. Federal grants come with reporting requirements, overhead rates and multi-year cycles that shape hiring and instrument purchases. Corporate funding tends to move faster but often carries intellectual property terms and publication restrictions that complicate academic careers and open-science obligations. A shift in the ratio between the two changes lab workflows, not just budgets.
War on the Rocks framing the question for a national security audience also matters. Defense policymakers have argued for years that the commercialization of US basic science — and the offshoring of manufacturing capacity that often follows — erodes the industrial base the Pentagon depends on. Who funds R&D, in that view, is inseparable from who controls the resulting capabilities.
The article joins a crowded field of analysis on the same question. Reports from the National Science Board's Science and Engineering Indicators, the American Association for the Advancement of Science's R&D budget program, and think tanks including the Brookings Institution and the Information Technology and Innovation Foundation have all tracked the public-private funding balance and its policy implications. What distinguishes a national security outlet engaging the question is the explicit link between research finance and strategic competition with China, whose own R&D spending growth has outpaced that of the United States for two decades.
Note on sourcing: the syndicated feed available to Hypothesis Wire contained the headline and publication attribution only, without the full article text. Readers should treat the specific figures, arguments and conclusions as attributable to the original War on the Rocks piece, which we have not independently verified. We are not quoting specific numbers from the article because the body text was not available in the feed; the contextual description of the US funding debate above reflects the established policy literature, not claims made in the source article itself.
For R&D portfolio managers, the piece is a prompt to revisit assumptions about funding concentration risk: how much of a lab's pipeline depends on a single federal agency's appropriations cycle, and how much private funding is positioned to fill gaps if federal priorities shift. The question of who pays is ultimately a question of who decides what gets researched.
The full analysis is available at War on the Rocks, which will presumably continue engaging science and technology policy questions through its national security lens.
via Google News: R&D funding (Source)
Filed under
- r-d-funding
- us-science-policy
- federal-research
- private-sector-r-d
- national-security
More from Tom Whitfield
Show full bio
Senior reporter covering media and advertising at Hypothesis Wire.
92 articles
References
- White House Science Report Urges Cutting University Research Funds
- U.S. Science Funding Cuts Raise Risk of Researcher Exodus
- States Weigh Own Science Funding as Federal Research Outlook Dims
- CBO Opens Preliminary Review of Federal Nondefense R&D Economic Effects
- Scientists Call Federal Move on Research Funding a 'Power Grab'